Skip to main content
. 2015 Oct 22;87(2):117–125. doi: 10.1136/jnnp-2015-311100

Figure 1.

Figure 1

Algorithm for MRI-based PML safety monitoring during natalizumab therapy, utilising anti-JCV antibody status and anti-JCV antibody index level. DWI, diffusion-weighted imaging; FLAIR, fluid-attenuated inversion recovery; MS, multiple sclerosis; PML, progressive multifocal leukoencephalopathy.